Technical Analysis for TMDX - TransMedics Group, Inc.

Grade Last Price % Change Price Change
A 92.08 3.17% 2.83
TMDX closed up 3.17 percent on Friday, April 26, 2024, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 30
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish 3.17%
NR7 Range Contraction 3.17%
Wide Bands Range Expansion 3.17%
Multiple of Ten Bearish Other 3.60%
Wide Bands Range Expansion 3.60%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 7 hours ago
60 Minute Opening Range Breakout about 10 hours ago
Rose Above Previous Day's High about 11 hours ago
Up 3% about 11 hours ago
Up 2% about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TransMedics Group, Inc. Description

TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Surgery Medical Technology Transplantation Organs Perfusion Transplantation Medicine Organ Failure Organ Transplantation Organ Transplant

Is TMDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 99.54
52 Week Low 36.4201
Average Volume 839,523
200-Day Moving Average 72.57
50-Day Moving Average 83.29
20-Day Moving Average 87.00
10-Day Moving Average 89.17
Average True Range 4.79
RSI (14) 59.84
ADX 24.18
+DI 28.64
-DI 14.80
Chandelier Exit (Long, 3 ATRs) 83.41
Chandelier Exit (Short, 3 ATRs) 84.71
Upper Bollinger Bands 100.71
Lower Bollinger Band 73.29
Percent B (%b) 0.69
BandWidth 31.52
MACD Line 2.44
MACD Signal Line 2.35
MACD Histogram 0.0929
Fundamentals Value
Market Cap 3.01 Billion
Num Shares 32.6 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -84.48
Price-to-Sales 15.17
Price-to-Book 22.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 96.44
Resistance 3 (R3) 96.23 94.57 95.72
Resistance 2 (R2) 94.57 93.45 94.67 95.47
Resistance 1 (R1) 93.32 92.77 93.94 93.53 95.23
Pivot Point 91.66 91.66 91.97 91.76 91.66
Support 1 (S1) 90.41 90.55 91.04 90.63 88.93
Support 2 (S2) 88.75 89.86 88.85 88.69
Support 3 (S3) 87.50 88.75 88.44
Support 4 (S4) 87.72